403 related articles for article (PubMed ID: 21931374)
1. Management of the metabolic effects of HIV and HIV drugs.
Brown TT; Glesby MJ
Nat Rev Endocrinol; 2011 Sep; 8(1):11-21. PubMed ID: 21931374
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease.
Anuurad E; Semrad A; Berglund L
Metab Syndr Relat Disord; 2009 Oct; 7(5):401-10. PubMed ID: 19355810
[TBL] [Abstract][Full Text] [Related]
3. Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection.
Barbaro G
Curr HIV Res; 2006 Jan; 4(1):79-85. PubMed ID: 16454713
[TBL] [Abstract][Full Text] [Related]
4. [Metabolic disturbances associated with HAART].
Olczak A
Przegl Epidemiol; 2007; 61(4):639-46. PubMed ID: 18572495
[TBL] [Abstract][Full Text] [Related]
5. Lipodystrophy and metabolic abnormalities in Slovenian HIV-infected patients.
Tomazic J; Silic A; Karner P; Vidmar L; Maticic M; Poljak M; Ihan A; Janez A
Wien Klin Wochenschr; 2004 Nov; 116(21-22):755-9. PubMed ID: 15628647
[TBL] [Abstract][Full Text] [Related]
6. Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case-control study.
Mercier S; Gueye NF; Cournil A; Fontbonne A; Copin N; Ndiaye I; Dupuy AM; Cames C; Sow PS; Ndoye I; Delaporte E; Simondon KB
J Acquir Immune Defic Syndr; 2009 Jun; 51(2):224-30. PubMed ID: 19339897
[TBL] [Abstract][Full Text] [Related]
7. [Lipodystrophy and lipid metabolism alterations in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
Calza L; Manfredi R; Chiodo F
Recenti Prog Med; 2004 May; 95(5):265-75. PubMed ID: 15202680
[TBL] [Abstract][Full Text] [Related]
8. [Lipid disorders in patients with HIV-induced diseases].
Chanu B; Valensi P
Presse Med; 2005 Sep; 34(15):1087-94. PubMed ID: 16334888
[TBL] [Abstract][Full Text] [Related]
9. Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy.
Falutz J
Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):651-61. PubMed ID: 17710086
[TBL] [Abstract][Full Text] [Related]
10. Toxic metabolic syndrome associated with HAART.
Haugaard SB
Expert Opin Drug Metab Toxicol; 2006 Jun; 2(3):429-45. PubMed ID: 16863444
[TBL] [Abstract][Full Text] [Related]
11. Lipotoxicity on the basis of metabolic syndrome and lipodystrophy in HIV-1-infected patients under antiretroviral treatment.
Giralt M; Díaz-Delfín J; Gallego-Escuredo JM; Villarroya J; Domingo P; Villarroya F
Curr Pharm Des; 2010 Oct; 16(30):3371-8. PubMed ID: 20687888
[TBL] [Abstract][Full Text] [Related]
12. HIV and increased risk of cardiovascular diseases.
Das S
Sex Health; 2005; 2(4):219-21. PubMed ID: 16402668
[TBL] [Abstract][Full Text] [Related]
13. [Criteria for AIDS-prices 2003. Why does HAART therapy in HIV patients cause fat catabolism?].
Urologe A; 2003 Sep; 42(9):1254. PubMed ID: 14619845
[No Abstract] [Full Text] [Related]
14. The metabolic syndrome, an epidemic among HIV-infected patients on HAART.
Jevtović DJ; Dragović G; Salemović D; Ranin J; Djurković-Djaković O
Biomed Pharmacother; 2009 Jun; 63(5):337-42. PubMed ID: 18996676
[TBL] [Abstract][Full Text] [Related]
15. Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients.
Barbaro G; Klatt EC
Curr Pharm Des; 2003; 9(18):1475-81. PubMed ID: 12769727
[TBL] [Abstract][Full Text] [Related]
16. [Metabolic changes in HIV infected patient].
Castelo Filho A; Abrão P
Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):5-7. PubMed ID: 17435849
[No Abstract] [Full Text] [Related]
17. Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management.
Gutierrez AD; Balasubramanyam A
Endocrine; 2012 Feb; 41(1):1-10. PubMed ID: 22134974
[TBL] [Abstract][Full Text] [Related]
18. The metabolic toxicities of antiretroviral therapy.
Herman JS; Easterbrook PJ
Int J STD AIDS; 2001 Sep; 12(9):555-62; quiz 563-4. PubMed ID: 11516363
[TBL] [Abstract][Full Text] [Related]
19. Metabolic complications of antiretroviral therapy in children.
Leonard EG; McComsey GA
Pediatr Infect Dis J; 2003 Jan; 22(1):77-84. PubMed ID: 12544413
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
Feleke Y; Fekade D; Mezegebu Y
Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
